LEA TENENHOLZ GRINBERG
Estados Unidos
Neuropathologist specializing in brain aging and associated
disorders, most notably, Alzheimer’s and neurological basis of sleep disturbances in neurodegenerative diseases. Currently, she is a Full Professor and a John Douglas French
Alzheimer’s Foundation Endowed Professor at the UCSF Memory and Aging Center, part of the
Executive Board of the Global Brain Health Institute and member of the Medical Scientific Advisory Group for the Alzheimer Association. She is also a Professor of Pathology at the University of Sao Paulo.
In 2003, Dr. Grinberg was among the founders of a brain bank in São Paulo, focusing on brain aging. This brain bank which she had since developed into an extremely prolific and highly-regarded institution, helped Dr. Grinberg prove that, contrary to what has been accepted
previously, the brainstem and not the cortex, harbors the first detectable neurodegeneration in Alzheimer’s disease. In 2009, she was the recipient of the UNESCO-L‘Oréal Award "For Women
in Science," and in 2010 she received the John Douglas French Alzheimer Foundation
"Distinguished Research Scholar Award." Currently, Dr. Grinberg is the Co-Leader of the UCSF/Neurodegenerative Disease Brain Bank, where she conducts neuropathological diagnosis of neurodegenerative diseases. She also directs the Human Biology Validation Core for the
NIH/U54 Tau Centers Without Walls, is a principal investigator from the Tau Consortium and co-lead the Neuropathology Core for the LEADS project.
Estados Unidos
Neuropathologist specializing in brain aging and associated
disorders, most notably, Alzheimer’s and neurological basis of sleep disturbances in neurodegenerative diseases. Currently, she is a Full Professor and a John Douglas French
Alzheimer’s Foundation Endowed Professor at the UCSF Memory and Aging Center, part of the
Executive Board of the Global Brain Health Institute and member of the Medical Scientific Advisory Group for the Alzheimer Association. She is also a Professor of Pathology at the University of Sao Paulo.
In 2003, Dr. Grinberg was among the founders of a brain bank in São Paulo, focusing on brain aging. This brain bank which she had since developed into an extremely prolific and highly-regarded institution, helped Dr. Grinberg prove that, contrary to what has been accepted
previously, the brainstem and not the cortex, harbors the first detectable neurodegeneration in Alzheimer’s disease. In 2009, she was the recipient of the UNESCO-L‘Oréal Award "For Women
in Science," and in 2010 she received the John Douglas French Alzheimer Foundation
"Distinguished Research Scholar Award." Currently, Dr. Grinberg is the Co-Leader of the UCSF/Neurodegenerative Disease Brain Bank, where she conducts neuropathological diagnosis of neurodegenerative diseases. She also directs the Human Biology Validation Core for the
NIH/U54 Tau Centers Without Walls, is a principal investigator from the Tau Consortium and co-lead the Neuropathology Core for the LEADS project.